Literature DB >> 1691675

Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids.

E Kelly1, M Keen, P Nobbs, J MacDermot.   

Abstract

1. Prostacyclin and adenosine A2 receptors activate adenylate cyclase in the neuroblastoma hybrid cell lines NG108-15 and NCB-20. Prolonged exposure of NG108-15 cells to iloprost (a stable analogue of prostacyclin) results in a subsequent reduction in the capacity for adenylate cyclase activation by iloprost, the adenosine analogue 5'-(N-ethyl)-carboxamidoadenosine (NECA) or NaF. In contrast prolonged exposure of NCB-20 cells to iloprost results only in the loss of iloprost responsiveness. 2. Iloprost pretreatment of NG108-15 cells also magnified the morphine-dependent inhibition of iloprost-stimulated adenylate cyclase activity from 36 to 48%. This change was not due to lower iloprost stimulation following desensitization, since the % inhibition of adenylate cyclase activity by morphine in control cells was constant irrespective of enzyme activity. 3. These heterologous effects observed in NG108-15 cells following iloprost pretreatment may involve changes in the GS alpha protein, since there was a reduction of about 30% in the cholera toxin-induced [32P]-ADP-ribosylation of a 45 kDa protein from cell membranes (corresponding to the extent of loss of NECA or NaF responsiveness). A similar reduction was not observed in NCB-20 cells. 4. These results indicate that iloprost pretreatment induces different forms of desensitization in NG108-15 and NCB-20 cell lines. The heterologous desensitization in the former may, like the human platelet, involve a functional loss of GS alpha from the cell membrane. Changes in the activity of GS alpha may also account for the heterologous effects on receptors that mediate inhibition of adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691675      PMCID: PMC1917398          DOI: 10.1111/j.1476-5381.1990.tb14700.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.

Authors:  R J Haslam; G M Rosson
Journal:  Mol Pharmacol       Date:  1975-09       Impact factor: 4.436

2.  Desensitization of prostacyclin responsiveness in platelets. Apparent differences in the mechanism in vitro or in vivo.

Authors:  J MacDermot
Journal:  Biochem Pharmacol       Date:  1986-08-15       Impact factor: 5.858

3.  Molecular cloning and sequence determination of cDNAs for alpha subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain.

Authors:  H Itoh; T Kozasa; S Nagata; S Nakamura; T Katada; M Ui; S Iwai; E Ohtsuka; H Kawasaki; K Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Inhibitory and stimulatory G proteins of adenylate cyclase: cDNA and amino acid sequences of the alpha chains.

Authors:  K A Sullivan; Y C Liao; A Alborzi; B Beiderman; F H Chang; S B Masters; A D Levinson; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase.

Authors:  K Jaschonek; C Faul; H Schmidt; W Renn
Journal:  Eur J Pharmacol       Date:  1988-03-01       Impact factor: 4.432

Review 6.  Roles of G protein subunits in transmembrane signalling.

Authors:  E J Neer; D E Clapham
Journal:  Nature       Date:  1988-05-12       Impact factor: 49.962

7.  ADP-ribosylation of membrane components by pertussis and cholera toxin.

Authors:  F A Ribeiro-Neto; R Mattera; J D Hildebrandt; J Codina; J B Field; L Birnbaumer; R D Sekura
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

8.  Opioid peptides promote cholera-toxin-catalysed ADP-ribosylation of the inhibitory guanine-nucleotide-binding protein (Gi) in membranes of neuroblastoma x glioma hybrid cells.

Authors:  G Milligan; F R McKenzie
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

Review 9.  Signal transduction by guanine nucleotide binding proteins.

Authors:  A M Spiegel
Journal:  Mol Cell Endocrinol       Date:  1987-01       Impact factor: 4.102

10.  Prostacyclin analogues reduce ADP-ribosylation of the alpha-subunit of the regulatory Gs-protein and diminish adenosine (A2) responsiveness of platelets.

Authors:  R J Edwards; J MacDermot; A J Wilkins
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

View more
  11 in total

1.  Internalization and down-regulation of the prostacyclin receptor in human platelets.

Authors:  S Giovanazzi; M R Accomazzo; O Letari; D Oliva; S Nicosia
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro.

Authors:  D K Rowlands; C Kao; H Wise
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

3.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

4.  NaF and guanine nucleotides modulate adenylate cyclase activity in NG108-15 cells by interacting with both Gs and Gi.

Authors:  E Kelly; M Keen; P Nobbs; J MacDermot
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

5.  Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.

Authors:  J E Merritt; T J Hallam; A M Brown; I Boyfield; D G Cooper; D M Hickey; A A Jaxa-Chamiec; A J Kaumann; M Keen; E Kelly
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

6.  The effect of calcium removal on the suppression by adenosine of epileptiform activity in the hippocampus: demonstration of desensitization.

Authors:  H Hosseinzadeh; T W Stone
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

7.  Gs alpha is a substrate for mono(ADP-ribosyl)transferase of NG108-15 cells. ADP-ribosylation regulates Gs alpha activity and abundance.

Authors:  L E Donnelly; R S Boyd; J MacDermot
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

8.  Concurrent down-regulation of IP prostanoid receptors and the alpha-subunit of the stimulatory guanine-nucleotide-binding protein (Gs) during prolonged exposure of neuroblastoma x glioma cells to prostanoid agonists. Quantification and functional implications.

Authors:  E J Adie; I Mullaney; F R McKenzie; G Milligan
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

9.  Regulation of cellular Gs alpha levels and basal adenylyl cyclase activity by expression of the beta 2-adrenoceptor in neuroblastoma cell lines.

Authors:  G Milligan; G D Kim; I Mullaney; E J Adie
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

10.  Agonist regulation of cellular Gs alpha-subunit levels in neuroblastoma x glioma hybrid NG108-15 cells transfected to express different levels of the human beta 2 adrenoceptor.

Authors:  E J Adie; G Milligan
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.